Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||KLH conjugated synthetic peptide between 104-132 amino acids from the C-terminal region of human HRASLS3|
|Purification||Ammonium sulfate precipitation, Size-exclusion - Dialysis|
|Contains||0.09% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1:10-1:50|
|Western Blot (WB)||1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PLA2G16 specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. It also has a weak lysophospholipase activity. Tumor suppressor that may be involved in interferon-dependent cell death.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Adipose-specific phospholipase A2; adipose-specific PLA2; AdPLA; Ca-independent phospholipase A1/2; Group XVI phospholipase A1/A2; group XVI phospholipase A2; H-rev 107 protein; H-rev 107 protein homolog; H-REV107-1; HRAS like suppressor 3; HRAS-like suppressor 1; HRAS-like suppressor 3; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; LRAT-like protein 3; phospholipase A2, group XVI; Renal carcinoma antigen NY-REN-65
AdPLA; C78643; H-rev107; H-REV107-1; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; MLP-3; PLA2G16